newsfilter
← Latest News
GlobeNewswire·

Filament Health to Present Live at VirtualInvestorConferences.com December 15th

VANCOUVER, British Columbia, Dec. 13, 2022 (GLOBE NEWSWIRE) -- Filament Health (OTCQB:FLHLF) (NEO:FH) (FSE:7QS), a clinical stage natural psychedelic drug development company, today announced that Benjamin Lightburn,